Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam 1105 AZ, the Netherlands.
Department of Integrative Structural and Computational Biology, Scripps CHAVI-ID, IAVI Neutralizing Antibody Center and Collaboration for AIDS Vaccine Discovery (CAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.
Cell Rep. 2017 Aug 22;20(8):1805-1817. doi: 10.1016/j.celrep.2017.07.077.
The production of native-like recombinant versions of the HIV-1 envelope glycoprotein (Env) trimer requires overcoming the natural flexibility and instability of the complex. The engineered BG505 SOSIP.664 trimer mimics the structure and antigenicity of native Env. Here, we describe how the introduction of new disulfide bonds between the glycoprotein (gp)120 and gp41 subunits of SOSIP trimers of the BG505 and other genotypes improves their stability and antigenicity, reduces their conformational flexibility, and helps maintain them in the unliganded conformation. The resulting next-generation SOSIP.v5 trimers induce strong autologous tier-2 neutralizing antibody (NAb) responses in rabbits. In addition, the BG505 SOSIP.v6 trimers induced weak heterologous NAb responses against a subset of tier-2 viruses that were not elicited by the prototype BG505 SOSIP.664. These stabilization methods can be applied to trimers from multiple genotypes as components of multivalent vaccines aimed at inducing broadly NAbs (bNAbs).
生产类似于 HIV-1 包膜糖蛋白 (Env) 三聚体的天然重组版本需要克服该复合物的天然灵活性和不稳定性。工程化的 BG505 SOSIP.664 三聚体模拟了天然Env 的结构和抗原性。在这里,我们描述了在 BG505 和其他基因型的 SOSIP 三聚体的 gp120 和 gp41 亚基之间引入新的二硫键如何提高它们的稳定性和抗原性,降低它们的构象灵活性,并有助于保持它们处于未结合构象。由此产生的下一代 SOSIP.v5 三聚体在兔子中诱导强烈的自体 tier-2 中和抗体 (NAb) 反应。此外,BG505 SOSIP.v6 三聚体诱导针对 tier-2 病毒亚群的弱异源 NAb 反应,而这些病毒亚群不能被原型 BG505 SOSIP.664 引发。这些稳定化方法可应用于多种基因型的三聚体,作为旨在诱导广泛中和抗体 (bNAb) 的多价疫苗的组成部分。